Frequent silencing of protocadherin 8 by promoter methylation, acandidate tumor suppressor for human gastric cancer

Oncology Reports

Volumn 28, Issue 5, 2012, Pages 1785-1791

  Zhang, Danjie ^a   Zhao, Wei ^a   Liao, Xinhua ^a   Bi, Tieqiang ^a   Li, Haijun ^a   Che, Xiangming ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

5 Aza 2 deoxycytidine; Gastric cancer; Gene methylation; Protocadherin 8

Indexed keywords

ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE LOCATION; GENE SILENCING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METHYLATION; MIGRATION INHIBITION; MOLECULAR PATHOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTOCADHERIN 8 GENE; SEQUENCE ANALYSIS; STOMACH CANCER; STOMACH CARCINOGENESIS; TUMOR SUPPRESSOR GENE; UPREGULATION;

APOPTOSIS; AZACITIDINE; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DNA METHYLATION; FEMALE; GASTRIC MUCOSA; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; STOMACH NEOPLASMS; UP-REGULATION;

EID: 84866450351     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1997     Document Type: Article

References (26)

1. Herszényi L and Tulassay Z: Epidemiology of gastrointestinal and liver tumors. Eur Rev Med Pharmacol Sci 14: 249-258, 2010.
2. Brenner H, Rothenbacher D and Arndt V: Epidemiology of stomach cancer. Methods Mol Biol 472: 467-477, 2009.
3. Arkenau HT: Gastric cancer in the era of molecularly targeted agents: current drug development strategies. J Cancer Res Clin Oncol 135: 855-866, 2009.
4. Yasui W, Sentani K, Motoshita J, et al: Molecular pathobiology of gastric cancer. Scand J Surg 95: 225-231, 2006. (Pubitemid 46089255)
5. Herman JG and Baylin SB: Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349: 2042-2054, 2003. (Pubitemid 37448928)
6. Wang JF and Dai DQ: Metastatic suppressor genes inactivated by aberrant methylation in gastric cancer. World J Gastroenterol 13: 5692-5698, 2007.
7. Machado JC, Oliveira C, Carvalho R, et al: E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncology 20: 1525-1528, 2001. (Pubitemid 32291203)
8. Esteller M, Corn PG, Baylin SB, et al: A gene hypermethylation profile of human cancer. Cancer Res 61: 3225-3229, 2001. (Pubitemid 32695003)
9. Buffart TE, Overmeer RM, Steenbergen RD, et al: MAL promoter hypermethylation as a novel prognostic marker in gastric cancer. Br J Cancer 99: 1802-1807, 2008.
10. Nishikawa Y, Miyazaki T, Nakashiro K, et al: Human FAT1 cadherin controls cell migration and invasion of oral squamous cell carcinoma through the localization of β-catenin. Oncol Rep 26: 587-592, 2011.
11. Gumbiner BM: Regulation of cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol 6: 622-634, 2005.
12. Batlle E, Sancho E, Franci C et al: The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2: 84-89, 2000.
13. Imoto I, Izumi H, Yokoi S, Hosoda H, et al: Frequent silencing of the candidate tumor suppressor PCDH20 by epigenetic mechanism in non-small-cell lung cancers. Cancer Res 66: 4617-4626, 2006.
14. Ying J, Li H, Seng TJ, Langford C, et al: Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophagealand multiple other carcinomas with frequent methylation. Oncogene 25: 1070-1080, 2006. (Pubitemid 43277014)
15. Haruki S, Imoto I, Kozaki K, et al: Frequent silencing of protocadherin 17, a candidate tumour suppressor for esophageal squamous-cell carcinoma. Carcinogenesis 31: 1027-1036, 2010.
16. Strehl S, Glatt K, Liu QM, et al: Characterization of two novel protocadherins (PCDH8 and PCDH9) localized on human chromosome 13 and mouse chromosome 14. Gemomics 53: 81-89, 1998. (Pubitemid 28489648)
17. Yu JS, Koujak S, Nagase S, et al: PCDH8, the human homolog of PAPC, is a candidate tumor suppressor of breast cancer. Oncogene 27: 4657-4665, 2008.
18. Herman JG, Graff JR, Myöhänen S, et al: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821-9826, 1996. (Pubitemid 26296693)
19. Gorringe KL, Ramakrishna M, Williams LH, et al: Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis. Genes Chromosomes Cancer 48: 931-942, 2009.
20. Franko J, Krasinskas AM, Nikiforova MN, et al: Loss of heterozygosity predicts poor survival after resection of pancreatic adenocarcinoma. J Gastrointest Surg 12: 1664-1672, 2008.
21. Chang YC, Yeh KT, Liu TC, et al: Molecular cytogenetic characterization of esophageal cancer detected by comparative genomic hybridization. J Clin Lab Anal 24: 167-174, 2010.
22. Ye Y, McDevitt MA, Guo M, et al: Progressive chromatin repression and promoter methylation of CTNNA1 associated with advanced myeloid malignancies. Cancer Res 69: 8482-8490, 2009.
23. Hukriede NA, Tsang TE, Habas R, et al: Conserved requirement of Lim1 function for cell movements during gastrulation. Dev Cell 4: 83-94, 2003. (Pubitemid 36105335)
24. Medina A, Swain RK, Kuerner KM and Steinbeisser H: Xenopus paraxial protocadherin has signaling functions and is involved in tissue separation. EMBO J 23: 3249-3258, 2004. (Pubitemid 39209149)
25. Unterseher F, Hefele JA, Giehl K, et al: Paraxial protocadherin coordinates cell polarity during convergent extension via Rho A and JNK. EMBO J 23: 3259-3269, 2004. (Pubitemid 39209150)
26. Tian K, Jurukovski V, Wang XP, et al: Epigenetic regulation of WTH3 in primary and cultured drugresistant breast cancer cells. Cancer Res 65: 10024-10031, 2005. (Pubitemid 41541484)